Why it's done

A PET scan is an effective way to examine the chemical activity in parts of your body. It may help identify a variety of conditions, including many cancers, heart disease and brain disorders. The pictures from a PET scan provide information different from that uncovered by other types of scans, such as computerized tomography (CT) or magnetic resonance imaging (MRI). A PET scan or a combined CT-PET scan enables your doctor to better diagnose illness and assess your condition.

Cancer

Cancer cells show up as bright spots on PET scans because they have a higher metabolic rate than do normal cells. PET scans may be useful in:

  • Detecting cancer
  • Revealing whether your cancer has spread
  • Checking whether a cancer treatment is working
  • Finding a cancer recurrence

PET scans must be interpreted carefully because noncancerous conditions can look like cancer, and some cancers do not appear on PET scans. Many types of solid tumors do appear on PET scans, including:

  • Brain
  • Cervical
  • Colorectal
  • Esophageal
  • Head and neck
  • Lung
  • Lymphoma
  • Melanoma
  • Pancreatic
  • Prostate
  • Thyroid

Heart disease

PET scans can reveal areas of decreased blood flow in the heart. This information can help you and your doctor decide, for example, whether you might benefit from a procedure to open clogged heart arteries (angioplasty) or coronary artery bypass surgery.

Brain disorders

PET scans can be used to evaluate certain brain disorders, such as tumors, Alzheimer's disease and seizures.

June 09, 2017
References
  1. Javery O, et al. FDG PET or PET/CT in patients with pancreatic cancer: When does it add to diagnostic CT or MRI? Clinical Imaging 37;2013:295.
  2. Murphy JG, et al., eds. Positron emission tomography. In: Mayo Clinic Cardiology: Concise Textbook. 4th ed. New York, N.Y.: Oxford University Press; 2013.
  3. Ziessman HA, et al. Nuclear Medicine: The Requisites. 4th ed. Philadelphia, Pa.: Saunders Elsevier; 2014.
  4. Positron emission tomography — Computed tomography (PET/CT). Radiological Society of North America. http://www.radiologyinfo.org/en/info.cfm?pg=PET. Accessed Feb. 8, 2017.
  5. About nuclear medicine and molecular imaging. Society of Nuclear Medicine and Molecular Imaging. http://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=6433&navItemNumber=756. Accessed Feb. 8, 2017.
  6. About PET scans. American College of Radiology Imaging Network. http://www.acrin.org/patients/aboutimagingexamsandagents/aboutpetscans.aspx. Accessed Feb. 8, 2017.
  7. Longo DL, et al., eds. Neuroimaging in neurologic disorders. In: Harrison's Principles of Internal Medicine. 19th ed. New York, N.Y.: McGraw-Hill Education; 2015. http://accessmedicine.com. Accessed Feb. 10, 2017.
  8. FDA approves production of imaging agent that helps detect prostate cancer. U.S. Food and Drug Administration. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm319201.htm. Accessed Feb. 2, 2017.
  9. Sobol I, et al. Contemporary mapping of post-prostatectomy prostate cancer relapse with C-choline positron emission tomography and multiparametric magnetic resonance imaging. Journal of Urology. 2017;197:129.
  10. Riggin EA. Decision Support System. Mayo Clinic, Rochester, Minn. Feb. 14, 2017.